NCT02070302 - BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Carpal Tunnel Syndrome

Interventions

DRUG

Botulinum Toxin Type A

40 units of BOTOX® (onabotulinumtoxin A) divided into two injection sites of 20 units each

DRUG

Placebo

Placebo (Normal Saline) divided into 2 injections of .4cc each

Trial Locations (1)

Arizona Arthritis & Rheumatology, Phoenix